219 related articles for article (PubMed ID: 10874763)
1. [Is there a place for interferon-alpha in the treatment strategy of multicentric Castleman's disease?].
Maloisel F; Andrès E; Campos F; Opréa C; Deslandres M; Randriamahazaka R; Kurtz JE; Koumarianou A; Dufour P
Rev Med Interne; 2000 May; 21(5):435-8. PubMed ID: 10874763
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha as first-line therapy for treatment of multicentric Castleman's disease.
Andrès E; Maloisel F
Ann Oncol; 2000 Dec; 11(12):1613-4. PubMed ID: 11205472
[No Abstract] [Full Text] [Related]
3. Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease.
Nord JA; Karter D
Int J STD AIDS; 2003 Jan; 14(1):61-2. PubMed ID: 12590797
[TBL] [Abstract][Full Text] [Related]
4. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hepatic relapse of multicentric Castleman's disease with transplantation.
Maloisel F; Andrès E; Chenard MP; Ellero B; Wolf P
Am J Med; 2003 Aug; 115(2):160-2. PubMed ID: 12893409
[No Abstract] [Full Text] [Related]
6. [Castleman's disease].
Larroche C; Cacoub P; Godeau P
Rev Med Interne; 1996; 17(12):1003-13. PubMed ID: 9008748
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of Behçet's disease in the course of multicentric HHV8-positive Castleman's disease: long-term complete remission by a combined chemo/radiation and interferon-alpha therapy regimen.
Strohal R; Tschachler E; Breyer S; Uthman A; Simonitsch I; Tratting S; Scheithauer W; Stingl G; Kornek GV
Br J Haematol; 1998 Dec; 103(3):788-90. PubMed ID: 9858232
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic multicentric Castleman's disease: a systematic literature review.
Liu AY; Nabel CS; Finkelman BS; Ruth JR; Kurzrock R; van Rhee F; Krymskaya VP; Kelleher D; Rubenstein AH; Fajgenbaum DC
Lancet Haematol; 2016 Apr; 3(4):e163-75. PubMed ID: 27063975
[TBL] [Abstract][Full Text] [Related]
9. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
Lee JP; Kim DK; Oh DY; Paik JH; Moon KC; Kim S; Kim YS
Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
[TBL] [Abstract][Full Text] [Related]
10. Multicentric Castleman's disease in a Ghanaian adult.
Dei-Adomakoh YA; Segbefia C; Ekem I; Taylor A
Ghana Med J; 2013 Jun; 47(2):92-5. PubMed ID: 23966747
[TBL] [Abstract][Full Text] [Related]
11. A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.
Takasawa N; Sekiguchi Y; Takahashi T; Muryoi A; Satoh J; Sasaki T
Mod Rheumatol; 2019 Jan; 29(1):198-202. PubMed ID: 27413814
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of human immunodeficiency virus-related Castleman's disease with interferon-alpha.
Kumari P; Schechter GP; Saini N; Benator DA
Clin Infect Dis; 2000 Aug; 31(2):602-4. PubMed ID: 10987728
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous castleman's disease responds to anti interleukin-6 treatment.
Ahmed B; Tschen JA; Cohen PR; Zaki MH; Rady PL; Tyring SK; Corringham RE; Kurzrock R
Mol Cancer Ther; 2007 Sep; 6(9):2386-90. PubMed ID: 17766835
[TBL] [Abstract][Full Text] [Related]
14. Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions.
Mochizuki H; Kato M; Higuchi T; Koyamada R; Arai S; Okada S; Eto H
Intern Med; 2017; 56(9):1095-1099. PubMed ID: 28458319
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
16. Is interferon-a an active agent in Castleman's disease?
Pavlidis NA; Briassoulis E; Klouvas G; Bai M
Ann Oncol; 1992 Jan; 3(1):85-6. PubMed ID: 1606076
[No Abstract] [Full Text] [Related]
17. Castleman's disease: from basic mechanisms to molecular therapeutics.
El-Osta HE; Kurzrock R
Oncologist; 2011; 16(4):497-511. PubMed ID: 21441298
[TBL] [Abstract][Full Text] [Related]
18. Human herpes virus 8 replication during disseminated tuberculosis in a man with human immunodeficiency virus: a case report.
Inoubli S; Toutous-Trellu L; Cathomas G; Oksenhendler E; Hirschel B; El Amari EB
J Med Case Rep; 2009 Nov; 3():113. PubMed ID: 19946591
[TBL] [Abstract][Full Text] [Related]
19. Multicentric Castleman's disease in two cases.
Sharma R; Seth R; Thavaraj V; Bagga A; Kabra SK; Karak AK; Atri S
Indian J Pediatr; 2007 Dec; 74(12):1116-20. PubMed ID: 18174650
[TBL] [Abstract][Full Text] [Related]
20. [Castleman's disease. Discussion related to case report].
Dănăilă C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2000; 104(3):133-41. PubMed ID: 12089914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
